Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. - Wikidata - wikimedia - TriplyDB

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

http://www.wikidata.org/entity/Q34355358

about

New drugs for treating dyslipidemia: beyond statins HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease.Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Effect of exposure to atmospheric ultrafine particles on production of free fatty acids and lipid metabolites in the mouse small intestine Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Adverse effects of hyperlipidemia on bone regeneration and strength.D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice HDL dysfunction in diabetes: causes and possible treatments.Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice A novel approach to oral apoA-I mimetic therapy Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.High-density lipoprotein mimetics: promises and challenges.Oxidized lipoprotein lipids and atherosclerosis.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia.

P2860

Q26821840-0925C1CE-874E-4935-BC0F-10A5497C5711 Q30251918-260FF429-98A6-4538-9F0C-CFD84988F15B Q33680333-D06B1A7F-CC46-442C-9848-92F7B71BC06F Q33956714-0A722CEF-8CBE-4B42-83EC-BCA7A834EEE6 Q34238630-76F28339-6698-43FE-A964-B77F2B920102 Q34594140-FF492C8F-7916-4A5B-9894-2E49F2E8410A Q34857041-3E57C414-4F35-499C-B78E-8AA6126B2E1F Q34955938-D8119029-5E2E-47FA-BAFB-EF978EFDE894 Q35212906-F679F76F-008A-4947-8E28-FC1C0AE9303A Q35217041-FF4FC99A-A874-4089-895F-23AA542246A5 Q35227165-CFC82E36-B486-4026-93CE-D08C1D26EA68 Q35742748-3DA5C075-25E5-4229-AEC1-069F2F51FCE4 Q35747768-691B0C3A-CD6B-47EF-BF32-E65B6B50BC31 Q35904110-7E8C7A96-8D34-4FED-BD2E-6AF7311DDA24 Q36585836-91CB19D0-DB75-4514-A9D4-B103F9F30541 Q36709656-FD9BC18E-5757-4147-8889-D4D86A9D08F1 Q36763561-E18E1D0E-DB9A-413C-A6E2-D22617385F4B Q37469181-115D9E57-716F-42CF-8315-B4F213477A8F Q37596528-53B1FCBE-C043-4DCA-86A0-3BD22B1A3CC0 Q37838234-0AB476EF-E336-492F-B48B-D55934BFE49A Q38639717-C828354A-6941-446E-A2F6-D6512103FF44 Q38650575-8D755E7D-5F0D-4A39-8E97-6DC2569F2866 Q38835291-DD0E8459-B602-41BA-A6C2-2F19E4685621 Q38965138-6C9147FE-0725-451B-89AA-BF27418B1327 Q47849940-68677F7F-5BDF-47E7-8255-DA1910F1680C

P2860

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

http://www.wikidata.org/entity/Q34355358

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@ast

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@en

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@nl

type

label

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@ast

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@en

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@nl

prefLabel

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@ast

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@en

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@nl

P1433

Q34355358-890E9F6C-1102-4D1C-B538-234DB4B0BB4D

P1476

Q34355358-2F8F2D92-C464-447E-965E-14BEB930EF70

P2093

Q34355358-09BF0DB4-AD62-4C7A-8CE0-F3B8D220E98A

Q34355358-1150CBFF-5479-4354-9B04-F2E6FE708D0C

Q34355358-1AFE6C74-2655-438E-B5FD-1951FC25116C

Q34355358-2D505115-B2CD-4987-9C76-F8F9AA1512D6

Q34355358-61CAA623-3038-46FF-969D-6098C1406290

P2860

Q34355358-0022E08E-3866-45F5-953C-705505D1C4B1

Q34355358-03DE164A-7799-4096-98D3-0BC79A0AF8E9

Q34355358-08EEAA58-FDDA-4F09-97F0-C1AF63C7D1B2

Q34355358-08F305D7-9387-4A67-A953-17640642B24B

Q34355358-0D961D66-08AB-4FA5-B7DC-4D999BB00158

Q34355358-19F43353-6BD3-4E9B-88BD-AB33CDC09D23

Q34355358-1AEEFE52-099D-4F4C-B8E8-46A0765DE74D

Q34355358-29B2F1A5-4A21-44FC-8B51-6EA4260E1CCB

Q34355358-405FADFA-05D6-4BC8-AD4D-4BA394CA5D8B

Q34355358-419895F8-8566-48FA-8A26-FC3C0543939D

P304

Q34355358-12961149-4C38-49D8-A197-F8E208BD561F

P31

Q34355358-31F91C75-0B3B-4E98-B87A-69CC6D7302E8

P356

Q34355358-D649DDC0-BE73-4170-B584-4EACD2C2FFE7

P407

Q34355358-F2A8BE71-80CB-4CFC-96D6-BC2A2E316A4C

P433

Q34355358-F31FF5C0-6360-4218-87AB-9821EAA43A86

P478

Q34355358-43EF1755-B517-429D-9BD1-1E9E92F655E1

P50

Q34355358-42D86DB6-189A-4496-99DA-D85528661D0A

P577

Q34355358-7BE3E343-CB3A-478C-8987-C565EF13AA8E

P5875

Q34355358-F6CA9EB9-0FC7-4C28-B713-A71FFD37D701

P698

Q34355358-7AE87797-209A-4EB4-9BDC-643965CCB582

P921

Q34355358-09E9EE3C-C9B8-45E2-B845-661C03782D3D

P932

Q34355358-95D76508-C611-4B26-A307-8FD8CB8AA232

P356

P1433

P1476

Apolipoprotein A-I mimetic pep ...... in a murine model of diabetes.

@en

P2093

Alan M Fogelman

http://www.w3.org/2001/XMLSchema#string

Mohamad Navab

http://www.w3.org/2001/XMLSchema#string

Satoshi Imaizumi

http://www.w3.org/2001/XMLSchema#string

Srinivasa T Reddy

http://www.w3.org/2001/XMLSchema#string

Victor Grijalva

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

Lipid peroxidation in diabetes mellitus.

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

Lipids and lipoproteins in patients with type 2 diabetes.

Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds

Quantitative assessment of atherosclerotic lesions in mice.

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.

Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

P304

3223-3228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0844

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Cecilia Morgantini

P577

2010-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46181049

http://www.w3.org/2001/XMLSchema#string

P698

20826564

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2992786

http://www.w3.org/2001/XMLSchema#string